ACE |
P12821
|
angiotensin I converting enzyme
|
Enzyme
|
1.0E-37 |
0.328 |
0.923 |
ADIPOQ |
Q15848
|
adiponectin, C1Q and collagen domain containing
|
|
4.6E-09 |
0.376 |
0.885 |
AGT |
P01019
|
angiotensinogen
|
Enzyme modulator
|
5.0E-08 |
0.367 |
0.923 |
AGTR1 |
P30556
|
angiotensin II receptor type 1
|
G-protein coupled receptor
|
5.3E-04 |
0.423 |
0.846 |
AIM2 |
O14862
|
absent in melanoma 2
|
|
2.2E-09 |
0.521 |
0.769 |
CASP1 |
P29466
|
caspase 1
|
Enzyme
|
3.5E-05 |
0.413 |
0.885 |
CASP3 |
P42574
|
caspase 3
|
Enzyme
|
0.10 |
0.351 |
0.923 |
CASP8 |
Q14790
|
caspase 8
|
Enzyme
|
3.7E-06 |
0.404 |
0.923 |
CCL2 |
P13500
|
C-C motif chemokine ligand 2
|
Signaling
|
0.61 |
0.321 |
0.962 |
CCR5 |
P51681
|
C-C motif chemokine receptor 5 (gene/pseudogene)
|
G-protein coupled receptor
|
4.3E-10 |
0.398 |
0.885 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
CRP |
P02741
|
C-reactive protein
|
|
3.7E-03 |
0.299 |
0.962 |
CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
CXCL12 |
P48061
|
C-X-C motif chemokine ligand 12
|
|
0.12 |
0.379 |
0.846 |
CXCL8 |
P10145
|
C-X-C motif chemokine ligand 8
|
Signaling
|
2.7E-04 |
0.310 |
0.962 |
CXCR3 |
P49682
|
C-X-C motif chemokine receptor 3
|
G-protein coupled receptor
|
0.18 |
0.436 |
0.808 |
EDN1 |
P05305
|
endothelin 1
|
Signaling
|
0.46 |
0.380 |
0.846 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
ELANE |
P08246
|
elastase, neutrophil expressed
|
Enzyme
|
1.2E-03 |
0.447 |
0.846 |
ESR1 |
P03372
|
estrogen receptor 1
|
Nuclear receptor
|
1.00 |
0.324 |
0.962 |
FCGR2A |
P12318
|
Fc fragment of IgG receptor IIa
|
Cell adhesion
|
2.0E-06 |
0.480 |
0.769 |
FCGR2B |
P31994
|
Fc fragment of IgG receptor IIb
|
Cell adhesion
|
0.46 |
0.522 |
0.846 |
FN1 |
P02751
|
fibronectin 1
|
Signaling
|
1.4E-03 |
0.365 |
0.962 |
FOXP3 |
Q9BZS1
|
forkhead box P3
|
|
0.99 |
0.368 |
0.846 |